Talecris Biotherapeutics Holdings Corp.’s ( TLCR) share price has entered into oversold territory with a stochastic value of 9.30. The Zacks Consensus Estimate on the company’s earnings for 2010 increased by 6 cents over the past month to $1.54 per share. Talecris is a Zacks #2 Rank (“Buy”) company.
 
Zacks Investment Research